Kalaris Therapeutics Inc (KLRS)
$4.10-1.20%Close
BUYRECOVERY · day 7
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $77M
- Avg volume
- 209.6K
- Beta
- 0.19
- P/E (TTM)
- -2.03
- Short % float
- 10.24%
- Days to cover
- 1.0
- SI change
- -20.9%
- 1W
- +3.54%
- 1M
- +9.92%
- 3M
- -16.67%
- YTD
- -50.60%
- vs SPY 1W
- +4.73%
- vs SPY 1M
- +6.60%
- vs SPY 3M
- -19.06%
- vs SPY YTD
- -62.36%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- EIKNBUYEikon Therapeutics, Inc. Common StockQ -15$11.16-2.02%
- KLRASELLKailera Therapeutics, Inc.Q -44$16.54-3.67%
- ABVXSELLAbivax S.A.BEARQ 61$116.15+1.04%
- ANNXSELLAnnexon, Inc.RECOVERYQ -7$5.06-0.20%
- CABABUYCabaletta Bio, Inc.RECOVERYQ -3$3.10-0.96%
- ERASSELLErasca, Inc.RECOVERYQ 6$17.60-0.17%
- MLTXSELLMoonLake ImmunotherapeuticsCRISISQ 4$15.37-2.47%
- MLYSSELLMineralys Therapeutics, Inc.RECOVERYQ 21$25.27-1.48%
- NDRASELLENDRA Life Sciences Inc.RECOVERYQ -20$4.56+1.56%
- PEPGBUYPepGen Inc.RECOVERYQ 1$3.19+1.59%
- PMVPBUYPMV Pharmaceuticals, Inc.RECOVERYQ -25$1.31-1.50%
- RVMDBUYRevolution Medicines, Inc.BULLQ 31$211.58+1.01%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 18
- VALUE
- 21
- GROWTH
- 47
- GARP
- 6
- TYPE
- Value / Recovery
Composite of Value · Growth · GARP
ROIC-43.0%
REV YoY-
ROE-71.7%
EPS YoY-
ROA-44.5%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-2.03
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B1.69
P/FCF-
EV/EBITDA-1.06
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E2.43
ALTMAN Z-
CURR RATIO10.98
ND/EBITDA-
BETA0.19
